TARS
NASDAQ · Pharmaceuticals
Tarsus Pharmaceuticals Inc
$65.33
+4.04 (+6.59%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-0.26%
1Y
+36.25%
YTD
-19.12%
Open$57.63
Previous Close$61.29
Day High$66.24
Day Low$57.63
52W High$85.25
52W Low$38.51
Volume—
Avg Volume896.8K
Market Cap2.56B
P/E Ratio—
EPS$-1.13
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$73.37
Below
SMA 200
$59.46
Above
RSI (14)
49.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+24.8% upside
Current
$65.33
$65.33
Target
$81.52
$81.52
$66.63
$81.52 avg
$107.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 468.69M | 141.37M | 563.29M |
| Net Income | -68,970,075 | -80,362,652 | 118.73M |
| Profit Margin | -14.7% | -60.0% | 21.1% |
| EBITDA | -72,805,603 | -89,061,843 | 174.10M |
| Free Cash Flow | — | — | 127.20M |
| Rev Growth | +159.5% | +47.5% | +0.6% |
| Debt/Equity | 0.21 | 0.32 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,189.35 | +1.67% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $257.21 | -0.15% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.63 | +0.23% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $25.98 | +0.64% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.09 | +0.72% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $76.68 | +3.07% | 12.1 | 32.02B |